Hester Biosciences was founded in 1987 by Mr Rajiv Gandhi, starting a journey that would see the company transform from a modest proprietary trading business to a leading force in the animal healthcare industry. Over the decades, Hester Biosciences has grown exponentially, focusing on the production and supply of poultry vaccines and animal health products. Today, it prides itself on being the second-largest poultry vaccine manufacturer in India and the largest one-stop animal biological manufacturing facility in Asia.
Its strategic expansion across the globe has seen it establish a presence in over 30 countries, with significant attention to India, Nepal, and Tanzania. This global reach attests to the company’s growth and its strategic vision of being an industry leader. Collaboration has been a part of Hester Biosciences’ growth strategy, partnering with various organizations such as the Bill & Melinda Gates Foundation, GALVmed, and the Golchha Organisation.
Currently, Hester Biosciences is not only a global leader in poultry vaccine manufacturing but also a pivotal contributor to animal and human health. The company’s endeavours extend beyond products to include services such as seroprofiling kits and diagnostic labs for poultry flocks and mastitis control programs for cattle. Its commitment to improving animal health and, by extension, human health positions it as a significant player in the global market. With its core values of integrity, innovation, trust, discipline, and passion, Hester Biosciences continues on its path of growth, driving forward the veterinary healthcare industry.
Strategic Partnerships
Over the years, Hester Biosciences has strategically aligned itself with several high-profile organizations, fostering partnerships that have significantly contributed to the company’s growth and its global impact in the animal healthcare industry.
Bill & Melinda Gates Foundation: Hester Biosciences’ collaboration with this reputed foundation underscores its commitment to health and development. The alliance has been crucial in developing vaccines that are affordable, accessible, and capable of addressing the needs of marginalized communities in developing countries.
GALVmed: Partnering with GALVmed, a global alliance focused on livestock veterinary medicines, has allowed Hester Biosciences to delve into the realm of developing innovative and effective livestock vaccines. This collaboration is a testament to the company’s dedication to eradicating animal diseases that pose threats to human health and economic stability.
Golchha Organisation and Novapharma: Through these partnerships, Hester Biosciences has significantly enhanced its market presence, particularly in the regions of Nepal and Egypt. These alliances have facilitated the introduction and distribution of Hester Biosciences’ products in these markets, furthering the company’s global reach.
Through these critical partnerships, Hester Biosciences continues its pursuit of innovation, broadening its global impact and solidifying its position as a leader in the animal healthcare industry.
Global Presence
Hester Biosciences maintains a robust presence in over 30 countries across the globe. A significant contributor to its international success is the company’s ability to adapt to the unique challenges and opportunities that each unique market presents.
India: As the second-largest poultry vaccine manufacturer in the country, Hester has made significant strides in India’s animal healthcare industry. The company’s headquarters in Ahmedabad, Gujarat, serves as a focal point for innovation, research, and production.
Nepal: In partnership with the Golchha Organisation, Hester has considerably expanded its reach in Nepal. This alliance has not only facilitated the distribution of Hester’s quality products but has also contributed to the company’s understanding of local market needs.
Tanzania: Hester’s strategic operations in Tanzania have played a significant role in addressing the local and regional animal health challenges. The company’s focus here extends to both poultry and livestock health, emphasizing the importance of holistic animal healthcare.
Egypt: Hester’s latest venture in Egypt, in collaboration with Novapharma, has marked its entry into a promising new market. This partnership aims to introduce and distribute Hester’s quality animal health products, thereby fulfilling the unmet needs of the Egyptian market.
Through these focused operations, Hester Biosciences continues to strengthen its status as a global leader in the animal healthcare industry, ensuring healthier animals and, by extension, healthier humans.
Animal and Poultry Health
Hester Biosciences has positioned itself as a vanguard in the realm of animal and poultry health, pioneering innovative solutions and products in the global animal vaccine and poultry market. The company’s significant efforts are directed towards enhancing animal health and preventing diseases, thereby creating a healthier world for both animals and humans.
Preventing Animal Diseases: At the heart of Hester Biosciences’ operations is a commitment to disease prevention. The company spearheads research and development initiatives aimed at creating effective vaccines for a wide range of animal diseases. This proactive approach helps in reducing outbreaks, minimizing the need for antibiotics, and ultimately enhancing the overall health and productivity of animals.
Improving Animal Health: Hester Biosciences’ comprehensive range of products, including various vaccines, health supplements, and diagnostic kits, are designed to bolster the well-being of animals. These products are developed with the utmost care, backed by extensive research, to ensure they meet the unique health needs of different animal species.
Global Animal Vaccine and Poultry Market: Hester Biosciences’ influence extends beyond the borders of India, reaching the global stage. As one of the world’s leading poultry vaccine manufacturers, the company plays a crucial role in shaping the global animal vaccine and poultry market. Its products are trusted by farmers and veterinarians across the globe, which is a testament to Hester Biosciences’ dedication to quality and efficacy.
In conclusion, Hester Biosciences’ relentless pursuits in improving animal health, preventing diseases, and contributing significantly to the global animal vaccine and poultry market underline its commitment to animal healthcare, embodying its vision of a healthier world for all.
Customer Centric Services.
Seroprofiling Kits: Hester Biosciences’ seroprofiling kits are one of the company’s valuable customer-centric services. These kits are designed to investigate the serological status of herds or flocks, providing valuable insights that can guide the implementation of effective vaccination strategies. They serve as a vital tool in preventive healthcare, allowing for the early detection of diseases and, thus, contributing to the overall well-being of animals.
Diagnostic Labs for Poultry Flocks: Understanding the critical importance of accurate and timely diagnosis, Hester Biosciences operates diagnostic labs specially designed for poultry flocks. These advanced laboratories offer a range of diagnostic tests, providing comprehensive health profiles of flocks. The labs are equipped with modern technology, allowing for the detection of a wide array of pathogens, which, in turn, helps in mitigating the risk of widespread disease outbreaks.
Mastitis Control Programs for Cattle: Mastitis, a significant challenge in dairy farming, can adversely affect the health of the cattle and the quality and quantity of milk production. Hester Biosciences’ mastitis control programs are a testament to the company’s commitment to improving cattle health and productivity. These programs offer a comprehensive approach to mastitis management, which includes disease detection, treatment, and prevention strategies. The aim is to reduce the incidence of mastitis, thereby enhancing the well-being of cattle and improving farm productivity.
These customer-centric services highlight Hester Biosciences’ proactive approach to addressing the diverse needs of its customers, reaffirming its position as a trusted partner in animal healthcare.
Core Values of Hester Biosciences
- Integrity: At Hester Biosciences, integrity is paramount. The company prides itself on conducting business with honesty and transparency, always striving to uphold the highest ethical standards. This strong moral compass is a cornerstone of everything Hester does, from its research practices to its customer interactions.
- Innovation: A spirit of innovation is deeply ingrained in Hester Biosciences. The company is committed to pioneering new solutions, pushing boundaries, and driving advancements in the animal healthcare industry. Its dedicated team of researchers and scientists tirelessly work to improve existing products and develop groundbreaking ones.
- Trust: Trust is a fundamental value at Hester Biosciences. It is instrumental in building lasting relationships with customers, partners, and stakeholders. The company not only aims to consistently deliver high-quality products that customers can rely on but also maintains transparency in all its operations to foster trust.
- Discipline: Hester Biosciences recognizes the importance of discipline in achieving excellence. The company is rigorous in its processes, meticulous in its research, and unyielding in its commitment to quality. This disciplined approach ensures that all functions of the company are executed with precision and efficiency.
- Passion: Passion is the fuel that drives Hester Biosciences. The company’s workforce is deeply passionate about enhancing animal health and contributing to a healthier world. This passion is reflected in their unwavering dedication to their work, their commitment to the company’s mission, and their zeal for making a difference in the animal healthcare sphere.
In essence, these core values not only guide Hester Biosciences’ operations but also define its character, shaping its approach towards animal healthcare and its vision for a healthier world.
Impact on Human Health.
Hester Biosciences’ efforts in enhancing animal health have profound implications for human health as well, particularly given the prevalence of zoonotic diseases – those that can be transmitted from animals to humans. The company’s robust vaccination programs and its focus on disease prevention help to curb the spread of such diseases, acting as a crucial line of defence in the global health ecosystem. This is particularly relevant in a world where pandemic threats are increasingly originating from zoonotic pathogens. By ensuring the health of animals, Hester Biosciences indirectly safeguards human health, underscoring the interconnectedness of all species and the importance of a holistic approach to health. This relationship further magnifies Hester Biosciences’ mission, extending its vision of a healthier world for all to not only include animal health but human health as well.
